GPS Wealth Strategies Group LLC Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GPS Wealth Strategies Group LLC cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.9% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 691 shares of the medical equipment provider’s stock after selling 76 shares during the quarter. GPS Wealth Strategies Group LLC’s holdings in Intuitive Surgical were worth $342,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Fifth Third Bancorp grew its stake in shares of Intuitive Surgical by 12.1% in the first quarter. Fifth Third Bancorp now owns 224,140 shares of the medical equipment provider’s stock worth $111,010,000 after acquiring an additional 24,208 shares during the last quarter. Simon Quick Advisors LLC raised its holdings in Intuitive Surgical by 15.7% in the 1st quarter. Simon Quick Advisors LLC now owns 2,466 shares of the medical equipment provider’s stock worth $1,221,000 after purchasing an additional 334 shares during the period. McKinley Carter Wealth Services Inc. lifted its holdings in Intuitive Surgical by 6.6% during the first quarter. McKinley Carter Wealth Services Inc. now owns 780 shares of the medical equipment provider’s stock valued at $386,000 after purchasing an additional 48 shares in the last quarter. EdgeRock Capital LLC purchased a new stake in Intuitive Surgical in the 1st quarter worth $260,000. Finally, Northeast Investment Management grew its position in shares of Intuitive Surgical by 3.7% during the first quarter. Northeast Investment Management now owns 92,474 shares of the medical equipment provider’s stock worth $45,800,000 after purchasing an additional 3,304 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president now directly owns 2,245 shares of the company’s stock, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 in the last quarter. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $513.00 on Friday. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The firm’s fifty day moving average is $525.48 and its 200 day moving average is $538.67. The firm has a market cap of $183.87 billion, a PE ratio of 80.03, a P/E/G ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Evercore ISI cut their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research report on Wednesday, April 23rd. Truist Financial lowered their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Piper Sandler reduced their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Royal Bank of Canada decreased their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Finally, Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.